NCT06012071 Two-piece Zirconia Implants With Two Various Platforms
| NCT ID | NCT06012071 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ljubljana |
| Condition | Edentulous Alveolar Ridge |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2022-07-03 |
| Primary Completion | 2026-07-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2022-07-03 with a primary completion date of 2026-07-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
24 patients with missing premolar teeth and healed sockets will be recruited. They will be randomized into two groups to supplied with tissue-level (n=12) or bone-level (n=12) 10-mm long 4-mm wide zirconia implants. Primary and secondary stabilities will be measured with International Stability Quotient (ISQ) device. After 3 months, ceramic crowns will be supplied. Implant survival rates and parameters in relation to periimplant soft-tissues and bone health and anatomy will be recorded and evaluated after 1, 3 and 5 years.
Eligibility Criteria
Inclusion Criteria: * Single missing maxillary premolar * Occlusal stability * Good oral hygiene * Good general health Exclusion Criteria: * Oral mucosa pathology * Dental caries * Active periodontitis (non-treated) * Systemic diseases and conditions that affect healing or immune capacity
Contact & Investigator
Rok Gašperšič, PhD
PRINCIPAL INVESTIGATOR
faculty of medicine
Frequently Asked Questions
Who can join the NCT06012071 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, studying Edentulous Alveolar Ridge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06012071 currently recruiting?
Yes, NCT06012071 is actively recruiting participants. Contact the research team at rok.gaspersic@mf.uni-lj.si for enrollment information.
Where is the NCT06012071 trial being conducted?
This trial is being conducted at Ljubljana, Slovenia.
Who is sponsoring the NCT06012071 clinical trial?
NCT06012071 is sponsored by University of Ljubljana. The principal investigator is Rok Gašperšič, PhD at faculty of medicine. The trial plans to enroll 24 participants.